Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2000
10/31/2000US6139818 Method of making ultrasonic contrast agent
10/31/2000US6139578 Preparation of cell seeded ceramic compositions
10/31/2000US6139574 Vascularized tissue regeneration matrices formed by solid free form fabrication techniques
10/31/2000US6138683 Smokeless tobacco products containing antioxidants
10/31/2000US6138680 Method for destroying retinal pigment epithelial cells
10/31/2000CA2204180C Melt-extruded orally administrable therapeutically active formulations
10/31/2000CA2189658C Controlled-release dosage forms of azithromycin
10/31/2000CA2182004C Film coated tablet of paracetamol and domperidone
10/31/2000CA2179305C Novel and improved aminoglycoside formulation for aerosolization
10/31/2000CA2036283C Effervescent composition, its production and use
10/31/2000CA2020955C Oral osmotic device with hydrogel driving member
10/30/2000CA2306502A1 Process for preparing spray granules containing riboflavin
10/26/2000WO2000063385A2 Nucleic acid immunization
10/26/2000WO2000063254A1 Haze-free cellulose ether capsules and process for making
10/26/2000WO2000063248A2 Highly purified gonadotropin compositions and process for preparing them
10/26/2000WO2000063218A1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents
10/26/2000WO2000062819A1 Formulations for detecting asthma
10/26/2000WO2000062818A1 Differentiation of monocytes into functional dendritic cells
10/26/2000WO2000062813A2 Cationic peg-lipids and methods of use
10/26/2000WO2000062810A1 An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport
10/26/2000WO2000062806A1 Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid
10/26/2000WO2000062801A2 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv)
10/26/2000WO2000062793A2 Pseudomycin antifungal compositions and methods for their use
10/26/2000WO2000062784A1 Pharmaceutical composition on the basis of erythromycin fatty acid salts for the topical treatment of skin diseases
10/26/2000WO2000062773A1 Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects
10/26/2000WO2000062769A2 Use of ap-1 activators to treat glaucoma and ocular hypertension
10/26/2000WO2000062764A1 Gum pad for delivery of medication to mucosal tissues
10/26/2000WO2000062763A2 Carrier patch for the delivery of agents to the skin
10/26/2000WO2000062762A1 Chewing gum with dental benefits including calcium in a food grade acid
10/26/2000WO2000062761A1 Process for microencapsulation of water soluble substances
10/26/2000WO2000062760A1 Ophthalmic insert and method for sustained release of medication to the eye
10/26/2000WO2000062759A1 Dry, mouldable drug formulation
10/26/2000WO2000062758A1 A method for improving the half-life of soluble viral-specific ligands on mucosal membranes
10/26/2000WO2000062757A1 Composition containing opioid antagonists and spray dispenser
10/26/2000WO2000062753A1 Pharmaceutical or cosmetic compositions for the local, intradermal application of hormones
10/26/2000WO2000062736A2 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
10/26/2000WO2000041662A8 Face mask or bandage
10/26/2000WO2000038695A3 Aciclovir compositions containing dimethicone
10/26/2000WO2000037099A3 Method for accelerating the rate of mucociliary clearance by using a kunitz-type serine protease inhibitor
10/26/2000WO2000037061A3 cGMP PDE 5 INHIBITORS FOR INHALATION IN THE TREATMENT OF SEXUAL DYSFUNCTION
10/26/2000WO2000037045A3 Stabilized water-in-oil-in-water antigen delivery system
10/26/2000WO2000035441A3 Pharmaceutical aerosol formulations containing fluoroalkanes, budesonide and formoterol
10/26/2000WO2000032169A3 Method for producing solid forms of administration by melt extrusion
10/26/2000WO2000025746A3 A process for the preparation of suspensions of drug particles for inhalation delivery
10/26/2000WO2000025671A9 Manganese compositions and methods for mri
10/26/2000WO2000019976A9 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them
10/26/2000WO2000013675A9 Methazolamide compositions and method of use
10/26/2000WO2000007577A3 Phosphatidylcholine as a medicament for the protection of mucosa
10/26/2000WO2000006151A9 Sustained release nitric oxide producing agents
10/26/2000WO1999021558A3 Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
10/26/2000DE19919308A1 Antipsoriatic composition containing proteolytic enzyme, preferably bromelain, removes harmful metabolites from epidermal basal layer cells to normalize skin structure
10/26/2000DE19918644A1 Intradermal composition for local treatment of skin aging or wrinkles, comprising matrix containing estrogen and structure former to minimize systemic side-effects
10/26/2000DE19918434A1 Storage-stable solid proton pump inhibitor formulation useful e.g. for treating duodenal ulcers, comprises amorphous active agent embedded in auxiliary matrix
10/26/2000DE19918325A1 Extruded drug dosage form, e.g. granulate for tableting, comprising an active agent in a polysaccharide-containing matrix, giving a release profile which is controllable by extrusion conditions and/or the inclusion of additives
10/26/2000DE19918324A1 Bactericidal, virucidal, fungicidal and antiprotozoal pharmaceutical composition, especially for ophthalmological use, contains benzalkonium salt
10/26/2000DE19918106A1 Transdermal patches containing basic or neutral drug include adhesive (meth)acrylic acid polymer in alkali(ne earth) metal salt form
10/26/2000DE19917548A1 Stable topical pharmaceutical composition for treating skin diseases, especially acne, contains erythromycin higher fatty acid salt in liquid or viscous carrier
10/26/2000DE10017883A1 Neues Behandlungsverfahren New treatment methods
10/26/2000CA2379105A1 An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport
10/26/2000CA2371942A1 Pseudomycin antifungal compositions and methods for their use
10/26/2000CA2370690A1 Cationic peg-lipids and methods of use
10/26/2000CA2370646A1 Nucleic acid immunization
10/26/2000CA2370268A1 Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid
10/26/2000CA2370146A1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents
10/26/2000CA2370130A1 Chewing gum with dental benefits including calcium in a food grade acid
10/26/2000CA2369808A1 Process for microencapsulation of water soluble substances
10/26/2000CA2369762A1 A method for improving the half-life of soluble viral-specific ligands on mucosal membranes
10/26/2000CA2369126A1 Use of ap-1 activators to treat glaucoma and ocular hypertension
10/26/2000CA2365579A1 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv)
10/26/2000CA2330022A1 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
10/25/2000EP1046396A2 Soy protein and plant sterol containing composition for the reduction of low density lipoprotein cholesterol concentration
10/25/2000EP1046395A1 Plaster for topical use containing heparin and diclofenac
10/25/2000EP1046394A2 Novel compositions useful for delivering compounds into a cell
10/25/2000EP1046389A1 Cosnetic composition in particular a make-up composition comprising a pyrrolopyrrole pigment
10/25/2000EP1045936A1 Aqueous compositions comprising complexing agents and uses therof
10/25/2000EP1045885A1 Alkylene oxide polymer compositions
10/25/2000EP1045825A1 Novel polyethoxylated castor oil, process of making the same and formulations thereof
10/25/2000EP1045736A1 Method for recovering medicaments from preparations, and from the precursors or wastes thereof
10/25/2000EP1045709A1 Method and device for in-situ formulation of a medicinal solution for parenteral application
10/25/2000EP1045703A1 Stabilization of lipid:dna formulations during nebulization
10/25/2000EP1045699A1 Genetic immunization with co-delivery of nucleic acid and cytokines in a single vehicle
10/25/2000EP1045696A1 Oral oil sorbing composition
10/25/2000EP1045695A1 Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f 1? to treat peripheral vascular disease
10/25/2000EP1045692A1 Skin protection composition
10/25/2000EP1045688A1 Lipomatrix preparation
10/25/2000EP1045686A1 Container for an inhalation anesthetic
10/25/2000EP1045681A1 METHOD AND COMPOSITIONS FOR $i(IN SITU) FORMATION OF PROTECTIVE AND/OR MEDICATED FILMS ON BODY TISSUE
10/25/2000EP1045676A1 Intravascular apparatus and method
10/25/2000EP1045648A1 Saccharide-based matrix comprising a maltodextrin, a gelling agent and a sugar
10/25/2000EP1045637A1 Decorated red blood cells
10/25/2000EP1024790A4 Injectable biodegradable block copolymer gels for use in drug delivery
10/25/2000EP0868485B1 Compositions comprising hydroxy-functional polymers
10/25/2000EP0804088B1 Stabilized composition comprising colistin sulfate
10/25/2000EP0785770B1 Hemorrhoidal compositions and method of use
10/25/2000EP0717617B1 Active principle and gas containing microparticles
10/25/2000EP0693923B1 Method for making a bioerodible material for the substained release of a medicament and the material made from the method
10/25/2000EP0635218B1 Taste modifying method and bitter taste reducing method
10/25/2000EP0627911B1 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
10/25/2000EP0601053B1 Compositions and methods for the sublingual or buccal administration of therapeutic agents
10/25/2000CN2402301Y Easy-to-place contraceptive suppository
1 ... 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 ... 2991